Quantifying Articulatory Coordination as a Biomarker for Schizophrenia
Not on the map. Why?
Abstract (arXiv)
Advances in artificial intelligence (AI) and deep learning have improved diagnostic capabilities in healthcare, yet limited interpretability continues to hinder clinical adoption. Schizophrenia, a complex disorder with diverse symptoms including disorganized speech and social withdrawal, demands tools that capture symptom severity and provide clinically meaningful insights beyond binary diagnosis. Here, we present an interpretable framework that leverages articulatory speech features through eigenspectra difference plots and a weighted sum with exponential decay (WSED) to quantify vocal tract coordination. Eigenspectra plots effectively distinguished complex from simpler coordination patterns, and WSED scores reliably separated these groups, with ambiguity confined to a narrow range near zero. Importantly, WSED scores correlated not only with overall BPRS severity but also with the balance between positive and negative symptoms, reflecting more complex coordination in subjects with pronounced positive symptoms and the opposite trend for stronger negative symptoms. This approach offers a transparent, severity-sensitive biomarker for schizophrenia, advancing the potential for clinically interpretable speech-based assessment tools.
Key facts. Cited by 1 paper in the map (data through 14 Oct 2026). Builds on 6 of its 17 references that are in the map. First posted on arXiv 5 Nov 2025.
Builds on
6 of 17 references.
References · 6
- 2020wav2vec 2.0: A Framework for Self-Supervised Learning of Speech Representationscited by 3,905
- 2023Improving Speech Inversion Through Self-Supervised Embeddings and Enhanced Tract Variablescited by 7
- 2024A Multimodal Framework for the Assessment of the Schizophrenia Spectrumcited by 4
- 2023A multi-modal approach for identifying schizophrenia using cross-modal attentioncited by 3
- 2024Speech-Based Estimation of Schizophrenia Severity Using Feature Fusioncited by 3
- 2025Multimodal Biomarkers for Schizophrenia: Towards Individual Symptom Severity Estimationcited by 3
Built on by
Citing papers per year: 2026: 1.
1 paper.